OUR PEOPLE SERVICES PUBLICATIONS APPROACH JOIN US DAVID MARDLE Partner Cambridge London View PDF Share GET IN TOUCH David Mardle is a partner in Goodwin’s Technology and Life Sciences group with 20 years of experience advising on financings and M&A transactions in the life sciences and technology sectors. Leveraging his significant M&A experience combined with his general corporate and capital markets expertise, Mr. Mardle now concentrates his focus on representing emerging companies providing counsel on corporate and capital markets transactions. Prior to joining Goodwin in 2019, Mr. Mardle was a partner at Taylor Wessing LLP. AREAS OF PRACTICE Life Sciences Life Sciences Europe Technology Propsci Technology Europe EXPERIENCE PUBLICATIONS IN THE NEWS CREDENTIALS GET IN TOUCH EXPERIENCE Mr. Mardle is one the longest-standing legal practitioners in the European venture capital community, and over the last 20 years has advised numerous companies seeking equity capital and those that invest in them on equity financings and M&A. PROFESSIONAL ACTIVITIES Mr. Mardle serves as secretary to Cambridge Network, a networking organization for business people and academics working in technology fields in the Cambridge area of the UK. The businesses and organizations that make up its membership are typical of those found in the “Cambridge Cluster” or Silicon Fen. Mr. Mardle is also a member of the working group of the British Venture Capital Association for the model documents for equity investment transactions. RECOGNITION Mr. Mardle was recognized by Chambers UK 2021 and 2022 for his work in Private Equity: Venture Capital Investment. Mr. Mardle is ranked in the top band for venture capital in Chambers UK, where he is described as a “very practical and commercial lawyer,” and as a Leading Individual and Recommended Lawyer in Legal 500 UK. 12 PUBLICATIONS “Standing Firm: Why Medtech Remains Robust During a Downturn,” MedTech Innovation News, September 2020 New and Noteworthy All Publications Alert - 2 Events - 1 Alert UK Listings Review: Do New Recommendations Change The Game for Tech And Life Sciences Companies? 16 March 2021 Alert UK ‘Future Fund’ Update 20 May 2020 Events SRS Acquiom 2019 Life Sciences M&A Study Launch Hosted by Goodwin November 19, 2019 London, England View More IN THE NEWS CREDENTIALS EDUCATION Bachelor of Arts Degree, Law, 1988 University of Oxford ADMISSIONS Bar Solicitor of the Senior Courts of England and Wales GET IN TOUCH Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us. GET IN TOUCH SEARCH OTHER LAWYERS Life Sciences Life Sciences Europe Technology Propsci Technology Europe Late Stage Drug Development VISITING GOODWIN YOU@GOODWIN ATTORNEY ADVERTISING LEGAL NOTICES PRIVACY POLICY COOKIE POLICY SECURE LOGIN SITE MAP Sign Up For Goodwin Updates Copyright © 2021 Goodwin Procter LLP By clicking “Accept All Cookies”, you agree to the storing of first and third party cookies on your device to enhance site navigation, analyze site usage, enable social media features and assist in our marketing efforts. Cookie Policy Cookies Settings Reject All Accept All Cookies